The Association for Diagnostics & Laboratory Medicine (ADLM) celebrates outstanding contributions to medicine through its annual awards program, which culminates with formal recognition at the ADLM Annual Meeting. Through this annual awards program, the association and its academy recognize individuals around the world for outstanding research and service in the field of laboratory medicine and related disciplined, and strive to raise awareness of the vital contribution made by all lab professionals to patient care.
Most awards go to those in the laboratory field, but some, such as the Wallace H. Coulter Lectureship Award, are often given to people from other disciplines.
Wallace H. Coulter Lectureship Award
David M. Nathan, MD
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts
Outstanding Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine
Alan Wu, PhD, DABCC, FACB
San Francisco General Hospital
University of California at San Francisco
San Francisco, CA
Outstanding Contributions Through Service to the Profession of Clinical Chemistry
Barbara Goldsmith, PhD, FADLM
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
Outstanding Contributions to Education in Clinical Chemistry
Veronica Luzzi, PhD, DABCC, FADLM
LuCitek LLC
Albuquerque, New Mexico
Outstanding Scientific Achievements by a Young Investigator
Nicholas Borcherding, MD, PhD
Barnes-Jewish Hospital
Washington University in St. Louis
St. Louis, Missouri
Medical Laboratory Scientist Achievement Award
Shawn Luby, MS, MLS(ASCP)CM
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Humans of ADLM - DEI Leadership Award (Individual Category)
Octavia M. Peck Palmer, PhD, PADLM
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Past President Award
Anthony A. Kileen, MD, BCh, PhD, DABCC, FADLM
University of Minnesota
Minneapolis, Minnesota
ADLM General Research Grant Recipient
William P.T.M. van Doorn
Maastricht University Medical Centre+
Maastricht, The Netherlands
Helen Free Travel Grant Recipient
Marisa Germaine, MLS(ASCP)CM SCCM
Vanderbilt University Medical Center
Nashville, Tennessee
The Academy of Diagnostics & Laboratory Medicine is pleased to announce that the following individuals have received a 2026 Academy Award. Congratulations to this year’s winners.
Qing H. Meng, PhD, MD, DABCC, FADLM
Professor and Section Chief
Clinical Chemistry and Special Chemistry Laboratories
Director of Postdoctoral Clinical Chemistry Fellowship Program
Department of Laboratory Medicine
The University of Texas MD Anderson Cancer Center
Catherine Omosule, PhD, DABCC, NRCC
Associate Medical Director of Pediatric Laboratory Services,
St. Louis Children's Hospital
Assistant Professor, Pathology and Immunology,
Washington University School of Medicine
Alan T. Remaley, MD, PhD
Senior Investigator
National Heart, Lung and Blood Institute
National Institutes of Health
A-007 – Robert Christenson, Baltimore, MD
Comparisons of High-Sensitivity Cardiac Troponin I Assays: Quantitative Differences in Non-Selectivity in Patient Samples.
A-014 – Asmita Hazra, Saguna, India
Evaluation of 82 LDL-Cholesterol Calculation Methods — 41 Formulae, 7 Lookup-Tables, 26 Machine Learning, and 8 Deep Learning Architectures — Against Direct LDL-C in over 26000 Eastern Indian Lipid Profiles.
A-097 – Sheng-Wei Pan, Taipei, Taiwan
Quantitative assessment of circulating blood ESAT-6 for non-sputum identification of pulmonary tuberculosis.
A-150 – Elikem Kumahor, Accra, Ghana
The Hidden Burden of Diabetes Mellitus: Impact of Sickle Cell Trait on HbA1c Measurement by Immunoassay vs. HPLC in a West African Population (Ghana).
A-157 – Yichen Ma, Beijing, China
Clinical Performance of LC-MS/MS and Immunoassays for Serum Thyroglobulin in Assessing Structural Disease in Differentiated Thyroid Cancer.
A-266 – Fabiano Mattesco, São Paulo, Brazil
Improving Laboratory Efficiency and Patient Safety Through Data-Driven Autoverification in Hematology and Coagulation.
A-349 – Wen Gu, Dallas, TX
A Dual-Marker Panel Predicts the Likelihood of Biliary Atresia in Infants with Superior Specificity than Current Practice.
B-017 – Audrianna Kern, Ankeny, IA
A Purified Recombinant Human Albumin Produced in Thermothelomyces heterothallica (C1) Better Mimics Native Human Serum Albumin than Recombinant Albumin from Other Expression Systems.
B-091 – Se-eun Koo, Seoul, Republic of Korea
Machine Learning–Enhanced Diagnostic Performance of Plasma Metanephrines in PPGL: A Large-Scale Real-World Clinical Cohort Study.
B-095 – Laisheng Li, Guangzhou, China
Precision Diagnosis of Early-Stage Hepatocellular Carcinoma: Development of a PIVKA-II Based Diagnostic Model.
B-123 – Ming Wang, Shenzehn, China
Explainable Machine Learning with CHI3L1 for Detecting Hepatocellular Carcinoma in a Multicenter Prospective Cohort study.
B-132 – Shujun Zhang, Jinan, China
DNA Methylation Profiling of Peripheral Blood Mononuclear Cells Unveils Systemic Immune Dysregulation and Enables Multi-Cancer Early Detection.
B-134 – Annalara Fischer, Louisville, KY
Integrating ctDNA Monitoring with Peripheral Immunophenotyping to Define Acquired Immunotherapy Resistance in Metastatic Melanoma.
B-194 – Qishui Ou, Fuzhou, China
Bile Acid Metabolomics Reveals Distinct Immunometabolic Niches and Enables Accurate Diagnosis of AQP4-IgG–Seronegative NMOSD.
B-321 – Yulin Ren, Xianyang, Shaanxi, China
Toward Deployable ddPCR: A Polycarbonate Integrated Platform with Stable Droplets, Broad Dynamic Range, and Low Consumable Cost.
B-350– Ryan Pearce, Rochester, MN
Clinical Validation of High-Resolution Mass Spectrometry for Blood-Based Minimal Residual Disease Detection to Reduce the Need for Bone Marrow Aspiration.
B-389 – Christian Grenier, Woburn, WA
A High-Throughput, Fully Automated Magnetic Bead-Based Extraction for Multi-Class Drug-of-Abuse Analysis in Oral Fluid.
B-402– Hannah Lusk, San Francisco, CA
Development of a Rapid Multiplex LC-MS/MS Assay for Therapeutic Drug Monitoring of Antituberculosis Drugs and Metabolites.
